Cargando…

Exploring existing and deliberated community perspectives of newborn screening: informing the development of state and national policy standards in newborn screening and the use of dried blood spots

OBJECTIVE: Since the 1960s newborn screening (NBS) for several rare and serious disorders has been in place across Australia. Testing of a simple blood spot now enables the early detection of over 30 conditions. Policies across Australian states have diverged in some aspects of NBS, especially in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muchamore, Ian, Morphett, Luke, Barlow-Stewart, Kristine
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1712344/ https://www.ncbi.nlm.nih.gov/pubmed/17164009 http://dx.doi.org/10.1186/1743-8462-3-14

Ejemplares similares

Influence of Hematocrit and Total-Spot Volume on Performance Characteristics of Dried Blood Spots for Newborn Screening
por: Hall, Elizabeth M., et al.
Publicado: (2015)

Creatine kinase‐MM concentration in dried blood spots from newborns and implications for newborn screening for Duchenne muscular dystrophy
por: Park, Sunju, et al.
Publicado: (2022)

Improved Dried Blood Spot PCR Assay for Universal Congenital Cytomegalovirus Screening in Newborns
por: Kim, Jean H., et al.
Publicado: (2023)

Expanding the Australian Newborn Blood Spot Screening Program using genomic sequencing: do we want it and are we ready?
por: White, Stephanie, et al.
Publicado: (2023)

Newborn Screening for Lysosomal Storage Disorders: Methodologies for Measurement of Enzymatic Activities in Dried Blood Spots
por: Gelb, Michael H., et al.
Publicado: (2018)

At-Risk Testing for Pompe Disease Using Dried Blood Spots: Lessons Learned for Newborn Screening
por: Lukacs, Zoltan, et al.
Publicado: (2020)

The view of Hong Kong parents on secondary use of dried blood spots in newborn screening program
por: Hui, L. L., et al.
Publicado: (2022)

Toward Newborn Screening of Cerebrotendinous Xanthomatosis: Results of a Biomarker Research Study Using 32,000 Newborn Dried Blood Spots
por: Hong, Xinying, et al.
Publicado: (2020)

Exploring the feasibility of using long-term stored newborn dried blood spots to identify metabolic features for congenital heart disease screening
por: Ceresnak, Scott R., et al.
Publicado: (2023)

Fragile X protein in newborn dried blood spots
por: Adayev, Tatyana, et al.
Publicado: (2014)

Storage stability of five steroids and in dried blood spots for newborn screening and retrospective diagnosis of congenital adrenal hyperplasia
por: Grecsó, Nóra, et al.
Publicado: (2020)

Comparison of different preparation techniques of dried blood spot quality controls in newborn screening for congenital adrenal hyperplasia
por: Grecsó, Nóra, et al.
Publicado: (2021)

Is Our Newborn Screening Working Well? A Literature Review of Quality Requirements for Newborn Blood Spot Screening (NBS) Infrastructure and Procedures
por: Odenwald, Birgit, et al.
Publicado: (2023)

Correction: Exploring the feasibility of using long-term stored newborn dried blood spots to identify metabolic features for congenital heart disease screening
por: Ceresnak, Scott R., et al.
Publicado: (2023)

Newborn Dried Blood Spots for Serologic Surveys of COVID-19
por: Liu, Feimei, et al.
Publicado: (2020)

Evaluation of the GSP Creatine Kinase-MM Assay and Assessment of CK-MM Stability in Newborn, Patient, and Contrived Dried Blood Spots for Newborn Screening for Duchenne Muscular Dystrophy
por: Migliore, Brooke A., et al.
Publicado: (2022)

2335. Newborn Dried Blood Spot for Retrospective Diagnosis of Congenital Cytomegalovirus (CMV) Infection: It’s Time for Universal Screening!
por: Medoro, Alexandra K, et al.
Publicado: (2019)

Preparing newborn screening for the future: a collaborative stakeholder engagement exploring challenges and opportunities to modernizing the newborn screening system
por: Andrews, Sara M., et al.
Publicado: (2022)

Newborn screening perspective.
por: Levy, H.
Publicado: (1991)

Newborn Screening in Slovenia
por: ŠMON, Andraž, et al.
Publicado: (2015)

Newborn screening in mucopolysaccharidoses
por: Donati, Maria Alice, et al.
Publicado: (2018)

NEWBORN HEARING SCREENING
Publicado: (2015)

Genomic newborn screening: public health policy considerations and recommendations
por: Friedman, Jan M., et al.
Publicado: (2017)

Defining the Newborn Blood Spot Screening Reference Interval for TSH: Impact of Ethnicity
por: Peters, Catherine, et al.
Publicado: (2016)

NBSTRN Tools to Advance Newborn Screening Research and Support Newborn Screening Stakeholders
por: Chan, Kee, et al.
Publicado: (2023)

Economic impact of screening for X-linked Adrenoleukodystrophy within a newborn blood spot screening programme
por: Bessey, Alice, et al.
Publicado: (2018)

Utility of measuring very long-chain fatty-acyl carnitines in dried blood spots for newborn screening of X-linked Adrenoleukodystrophy
por: Natarajan, Archana, et al.
Publicado: (2021)

Analysis of a pitfall in congenital adrenal hyperplasia newborn screening: evidence of maternal use of corticoids detected on dried blood spot
por: Houang, Muriel, et al.
Publicado: (2022)

Using dried blood spot on HemoTypeSC™, a new frontier for newborn screening for sickle cell disease in Nigeria
por: Okeke, Chinwe O., et al.
Publicado: (2022)

Multi-Laboratory Evaluation of Prototype Dried Blood Spot Quality Control Materials for Creatine Kinase-MM Newborn Screening Assays
por: Dantonio, Paul, et al.
Publicado: (2023)

Duchenne muscular dystrophy newborn screening: the first 50,000 newborns screened in Taiwan
por: Chien, Yin-Hsiu, et al.
Publicado: (2022)

Analysis of archived residual newborn screening blood spots after whole genome amplification
por: Cantarel, Brandi L., et al.
Publicado: (2015)

Policy Making in Newborn Screening Needs a Structured and Transparent Approach
por: Jansen, Marleen E., et al.
Publicado: (2017)

Is Newborn Hearing Screening Cost Effective? Economic Consideration for Policy Makers
por: Jafarlou, Fatemeh, et al.
Publicado: (2021)

Application of a diagnostic methodology by quantification of 26:0 lysophosphatidylcholine in dried blood spots for Japanese newborn screening of X-linked adrenoleukodystrophy
por: Wu, Chen, et al.
Publicado: (2017)

Conductive impairment in newborn who failed the newborn hearing screening
por: Pereira, Priscila Karla Santana, et al.
Publicado: (2015)

Parental Attitudes Toward Standard Newborn Screening and Newborn Genomic Sequencing: Findings From the BabySeq Study
por: Armstrong, Brittan, et al.
Publicado: (2022)

Determining Reference Ranges for Total T(4) in Dried Blood Samples for Newborn Screening
por: Hijman, Anna-Isabella, et al.
Publicado: (2020)

New technologies in newborn screening.
por: Naylor, E. W.
Publicado: (1991)

Screening of the hearing of newborns - Update
por: Schnell-Inderst, Petra, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_j3bs95cl5n33aguif787ctlmrq